Overview
Lobbying Costs
400,000€ - 499,999€
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Jazz Pharmaceuticals plc
EU Transparency Register
886415644901-92 First registered on 20 Dec 2021
Goals / Remit
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early-to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com.
Main EU files targeted
Main EU legislative proposals or policies :
EU4 Health Programme
EU Pharmaceutical Strategy
Evaluation of the Orphan Medicinal Products (OMP) and Paediatric regulations
Horizon Europe (research programme)
The Innovative Medicine Initiative (IMI)Address
Head Office
Jazz Pharmaceuticals plc Waterloo Exchange Waterloo Road
Dublin Dublin 4
IRELANDEU Office
Jazz Pharmaceuticals PLC 1 Cavendish Place
London W1G 0QF
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
2 colleagues spend between 10% and 20% of their time on EU Affairs.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
EUCOPE
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
400,000€ - 499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount incisive health 25,000€ - 49,999€ interel 300,000€ - 399,999€ Intermediaries for current year
Name incisive health interel Closed year Costs
400,000€ - 499,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
GW Pharmaceuticals (now part of Jazz Pharmaceuticals) contributed to the EU Pharmaceutical Strategy Roadmap (7 July 2020)
GW (now part of Jazz Pharmaceuticals) contributed to the EU Pharmaceutical Strategy Open Consultation (15 September 2020)
Jazz Pharmaceuticals contributed to the EU Open Public Consultation on the Revision of EU Rules on Medicines for Children and Rare Diseases (30 July 2021)Other activities
None declared
Meetings
Meetings
None declared